In vitro selection of DNA aptamers that block toxic effects of AGE on cultured retinal pericytes

Microvascular Research

Volumn 74, Issue 1, 2007, Pages 65-69

  Higashimoto, Yuichiro ^a   Yamagishi, Sho ichi ^a   Nakamura, Kazuo ^a   Matsui, Takanori ^a   Takeuchi, Masayoshi ^b   Noguchi, Masato ^a   Inoue, Hiroyoshi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

Author keywords

AGE; Diabetic retinopathy; DNA aptamer; Pericyte loss

Indexed keywords

ADVANCED GLYCATION END PRODUCT; APTAMER; DNA;

ANIMAL CELL; ARTICLE; CATTLE; CELL PROTECTION; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; CYTOTOXICITY; DIABETIC RETINOPATHY; DNA SYNTHESIS INHIBITION; HOMEOSTASIS; IN VITRO STUDY; MICROVASCULATURE; NONHUMAN; PERICYTE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CATTLE; CELL SURVIVAL; CELLS, CULTURED; DRUG ANTAGONISM; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MOLECULAR SEQUENCE DATA; PERICYTES; RETINA; SELEX APTAMER TECHNIQUE; SERUM ALBUMIN;

EID: 34249815197     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2007.04.001     Document Type: Article

References (12)

1. Capetandes A., and Gerritsen M.E. Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes. Investig. Ophthalmol. Vis. Sci. 31 (1990) 1738-1744
2. Esmaili N., and Leroy J.I. i-motif solution structure and dynamics of the d(AACCCC) and d(CCCCAA) tetrahymena telomeric repeats. Nucleic Acids Res. 33 (2005) 213-224
3. Lee J.F., Stovall G.M., and Ellington A.D. Aptamer therapeutics advance. Curr. Opin. Chem. Biol. 10 (2006) 282-289
4. Okahata Y., Niikura K., Sugiura Y., Sawada M., and Morii T. Kinetic studies of sequence-specific binding of GCN4-bZIP peptides to DNA strands immobilized on a 27-MHz quartz-crystal microbalance. Biochemistry 37 (1998) 5666-5672
5. Okazawa A., Maeda H., Fukusaki E., Katakura Y., and Kobayashi A. In vitro selection of hematoporphyrin binding DNA aptamers. Bioorg. Med. Chem. Lett. 10 (2000) 2653-2656
6. Orlidge A., and D'Amore P.A. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol. 105 (1987) 1455-1462
7. Rahbah S., and Figarola J.L. Novel inhibitors of advanced glycation end products. Arch. Biochem. Biophys. 419 (2003) 63-79
8. Yamagishi S., and Imaizumi T. Pericyte biology and diseases. Int. J. Tissue React. 27 (2005) 125-135
9. Yamagishi S., and Imaizumi T. Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr. Pharm. Des. 11 (2005) 2279-2299
10. Yamagishi S., Kobayashi K., and Yamamoto H. Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. Biochem. Biophys. Res. Commun. 190 (1993) 418-425
11. Yamagishi S., Inagaki Y., Amano S., Okamoto T., Takeuchi M., and Makita Z. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochem. Biophys. Res. Commun. 296 (2002) 877-882
12. Yamagishi S., Inagaki Y., Okamoto T., Amano S., Koga K., Takeuchi M., and Makita Z. Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J. Biol. Chem. 277 (2002) 20309-20315